Hydrazine sulfate: A current perspective

References

• Chlebowski , RT , Grosvenor , M , Scrooc , M , Byerley , L Chlebowski , JS . 1985 . “Influence of Hydrazine Sulfate on Food Intake and Weight Maintenance in Patients With Cancer (abstr)” . Proc Am Soc Clin Oncol , 4 : 265
   Google Scholar
• Chlebowski , RT , Heber , D , Richardson , B and Block , JB . 1984 . “Influence of Hydrazine Sulfate on Abnormal Carbohydrate Metabolism in Cancer Patients With Weight Loss” . Cancer Res , 44 : 857 – 861 .
   PubMed Web of Science ®Google Scholar
• Gold , J . 1974 . “Cancer Cachexia and Gluconeogenesis” . Ann NY Acad Sci , 230 : 103 – 110 .
   PubMed Web of Science ®Google Scholar
• Holroyde , CP , Gabuzda , TG , Putnam , RC , Paul , P and Reichard , GA . 1975 . “Altered Glucose Metabolism in Metastatic Carcinoma” . Cancer Res , 35 : 3710 – 3714 .
   PubMed Web of Science ®Google Scholar
• Burt , ME , Lowry , SF , Gorschboth , C and Brennan , MF . 1981 . “Metabolic Alterations in a Non‐Cachectic Animal Tumor System” . Cancer , 47 : 2138 – 2146 .
   PubMed Web of Science ®Google Scholar
• Heber , D , Chlebowski , RT , Ishibushi , DE , Herrold , JN and Block , JB . 1982 . “Abnormalities in Glucose and Protein Metabolism in Noncachectic Lung Cancer Patients” . Cancer Res , 42 : 4815 – 4819 .
   PubMed Web of Science ®Google Scholar
• Gershanovich , ML , Danova , LA , Ivin , BA and Filov , VA . 1981 . “Results of Clinical Study of Antitumor Action of Hydrazine Sulfate” . Nutr Cancer , 3 : 7 – 12 .
   PubMedGoogle Scholar
• Gold , J . 1968 . “Proposed Treatment of Cancer by Inhibition of Gluconeogenesis” . Oncology , 22 : 185 – 207 .
   PubMed Web of Science ®Google Scholar
• Ray , PD and Hanson , RL . 1969 . “Inhibition of Gluconeogenesis by Hydrazine (abstr)” . Fed Proc , 28 : 411
   Google Scholar
• Ray , PD , Hanson , RL and Lardy , HA . 1970 . “Inhibition by Hydrazine of Gluconeogenesis in the Rat” . J Biol Chem , 245 : 690 – 696 .
   PubMed Web of Science ®Google Scholar
• Gold , J . 1970 . “Inhibition of Walker 256 Intramuscular Carcinoma in Rats by Administration of L‐Tryptophan and Hydrazine Sulfate (abstr)” . Proc Am Assoc Cancer Res , 11 : 30
   Google Scholar
• Gold , J . 1971 . “Inhibition of Walker 256 Intramuscular Carcinoma in Rats by Administration of Hydrazine Sulfate” . Oncology , 25 : 66 – 71 .
   PubMed Web of Science ®Google Scholar
• Gold , J . 1973 . “Inhibition by Hydrazine Sulfate and Various Hydrazides, of In‐Vivo Growth of Walker 256 Intramuscular Carcinoma, B‐16 Melanoma, Murphy‐Sturm Lymphosarcoma and L‐1210 Solid Leukemia” . Oncology , 27 : 69 – 80 .
   PubMed Web of Science ®Google Scholar
• Dilman , VH , Anisomov , VN , Kolosov , AI and Bulovskaya , LN . 1976 . “On the Relationship Between the Activity of Acetylations, Growth of Experimental Tumors and Efficacy of Their Suppression by Hydrazine Sulfate” . Oncol‐ogy , 33 : 219 – 221 .
   PubMed Web of Science ®Google Scholar
• Grubbs , B , Rogers , W and Cameron , I . 1978 . “Combining Total Parenteral Nutrition and Inhibition of Gluconeogenesis to Overcome Cancer Cachexia (abstr)” . Proc Am Assoc Cancer Res , 19 : 69
   Google Scholar
• Gold , J . 1975 . “Enhancement by Hydrazine Sulfate of Antitumor Effectiveness of Cytoxan, Mitomycin‐C, Metho‐trexate and Bleomycin, in Walker 256 Carcinosarcoma in Rats” . Oncology , 31 : 44 – 53 .
   PubMed Web of Science ®Google Scholar
• Gold , J . 1978 . “Potentiation by Clofibrate of In‐ Vivo Tumor Inhibition by Hydrazine Sulfate and Cytotoxic Agents, in Walker 256 Carcinosarcoma” . Cancer Biochem Biophys , 3 : 41 – 45 .
   PubMedGoogle Scholar
• Tretyakov , AV and Filov , VA . 1977 . “The Mechanism of Potentiation by Hydrazine Sulfate of Action of Antitumoral Compounds” . Vopr Onkol , 23 : 94 – 98 .
   Google Scholar
• Grubbs , B , Rogers , W and Cameron , I . 1979 . “Total Parenteral Nutrition and Inhibition of Gluconeogenesis on Tumor‐Host Responses” . Oncology , 36 : 216 – 223 .
   PubMed Web of Science ®Google Scholar
• Gold , J . 1973 . “Inhibition of gluconeogenesis at the Phosphoenolpyruvate Carboxykinase Level, as a Means of Cancer Chemotherapy (abstr)” . Proc Am Assoc Cancer Res , 14 : 9
   Google Scholar
• Gold , J . 1974 . “Inhibition of Gluconeogenesis at the Phosphoenolpyruvate Carboxykinase and Pyruvate Carboxylase Reactions, as a Means of Cancer Chemotherapy” . Oncology , 29 : 74 – 89 .
   PubMed Web of Science ®Google Scholar
• Gold , J . 1974 . “Use of Hydrazine Sulfate in Advanced Cancer Patients: Preliminary Results (abstr)” . Proc Am Assoc Cancer Res , 15 : 83
   Google Scholar
• Gold , J . 1975 . “Use of Hydrazine Sulfate in Terminal and Preterminal Cancer Patients: Results of Investigational New Drug (IND) Study in 84 Evaluable Patients” . Oncology , 32 : 1 – 10 .
   PubMed Web of Science ®Google Scholar
• Seits , JF , Gershanovich , ML , Filov , VA , Danova , LA Kondratyev , VB . 1975 . “Experimental and Clinical Data on the Antitumor Action of Hydrazine Sulfate” . Vopr Onkol , 21 : 45 – 52 .
   PubMedGoogle Scholar
• Gershanovich , ML , Danova , LA , Kondratyev , VB , Malyugina , LL Stukov , AN . 1976 . “Clinical Data on the Antitumor Activity of Hydrazine Sulfate” . Cancer Treat Rep , 60 : 933 – 935 .
   PubMedGoogle Scholar
• Danova , LA , Kondratyev , VB , Gershanovich , ML and Filov , VA . 1977 . “Results of Administration of Hydrazine Sulfate to Patients With Hodgkins Disease” . Ther Arch Vopr Hematol , 29 : 45 – 47 .
   Google Scholar
• Lerner , HJ and Regelson , W . 1976 . “Clinical Trial of Hydrazine Sulfate in Solid Tumors” . Cancer Treat Rep , 60 : 959 – 960 .
   PubMedGoogle Scholar
• Spremulli , E , Wampler , GL and Regelson , W . 1979 . “Clinical Study of Hydrazine Sulfate in Advanced Cancer Patients” . Cancer Chemother Pharmacol , 3 : 121 – 124 .
   PubMed Web of Science ®Google Scholar
• Ochoa , M Jr , Wittes , RE and Krakoff , IH . 1975 . “Trial of Hydrazine Sulfate (NSC‐150014) in Patients With Cancer” . Cancer Chemother Rep , 58 : 1151 – 1154 .
   Google Scholar
• Gold , J . 1976 . “Hydrazine Sulfate in the Treatment of Cancer” . Cancer Treat Rep , 60 : 964
   PubMedGoogle Scholar
• Leff , DN . 1974 . “Hydrazine Therapy for Cancer: The Pros and Cons” . Med World News , 15 (24) : 32 – 33 .
   Google Scholar
• Gold , J . 1977 . “Incompatibility of Hydrazine Sulfate and Pentobarbital in the Treatment of Tumor Bearing Animals (abstr)” . Proc Am Assoc Cancer Res , 18 : 250
   Google Scholar
• Danova , LA , Gershanovich , ML , Filov , VA , Kondratyev , VB and Ivin , VA . 1977 . “Study of Side Effects of Hydrazine Sulfate” . In Problems in Radiobiology and Biological Action of Cytostatic Compounds , Edited by: Goldberg , ED . 192 – 193 . Tomsk, , USSR : Tomsk Institute of Medicine .
   Google Scholar
• Gershanovich , ML and Filov , VA . 1979 . “Hydrazine Sulfate in Late‐Stage Cancer: Completion of Initial Clinical Trials in 225 Evaluable Patients (abstr)” . Proc Am Assoc Cancer Res , 20 : 240
   Google Scholar
• Filov , VA , Danova , LA , Gershanovich , ML , Tretyakov , AV and Ivin , VA . 1983 . “Hydrazine Sulfate: Experimental and Clinical Results, Mechanism of Action” . In Medical Therapy of Tumors , Edited by: Filov , VA , Ivin , VA and Gershanovich , ML . 92 – 139 . Leningrad : USSR Ministry of Health .
   Google Scholar
• Chlebowski , RT , Heber , D , Richardson , B , Henson , LC Chi , J . 1983 . “Association Between Improved Carbohydrate Metabolism and Weight Maintenance in Hydrazine Sulfate Treated Patients With Cancer Cachexia (abstr)” . Proc Am Soc Clin Oncol , 2 : 95
   Google Scholar
• Gold , J . 1981 . “Anabolic Profiles in Late‐Stage Cancer Patients Responsive to Hydrazine Sulfate” . Nutr Cancer , 3 : 13 – 19 .
   PubMedGoogle Scholar
• Creagan , ET , Moertel , CG , O'Fallon , JR , Schutt , AJ O'Connell , MJ . 1979 . “Failure of High Dose Vitamin C (Ascorbic Acid) Therapy to Benefit Patients With Advanced Cancer” . N Engl J Med , 301 : 687 – 690 .
   PubMed Web of Science ®Google Scholar
• Gold , J . 1979 . “Hydrazine Sulfate and Cancer Cachexia” . Nutr Cancer , 1 : 4 – 9 .
   Google Scholar
• Chlebowski , RT , Dietrich , M , Tsmokai , R and Block , JB . 1985 . “Hydrazine Sulfate: Clinical Pharmacokinetics and Influence on In Vitro Growth of Human Glioblastoma Cell Lines (abstr)” . Proc Am Assoc Cancer Res , 26 : 254
   Google Scholar
• Robins , S , ed. 1957 . Textbook of Pathology , Philadelphia : Saunders .
   Google Scholar
• Costa , G , Lane , WW , Vincent , RG , Siebold , JA Aragon , M . 1980 . “Weight Loss and Cachexia in Lung Cancer” . Nutr Cancer , 2 : 98 – 103 .
   Google Scholar
• Terepka , AR and Waterhouse , C . 1956 . “Metabolic Observations During the Forced Feeding of Patients With Cancer” . Am J Med , 20 : 225 – 237 .
   PubMed Web of Science ®Google Scholar
• Watkin , DM . 1961 . “Nitrogen Balance as Affected by Neoplastic Disease and Its Therapy . Am J Clin Nutr , 9 : 446 – 460 .
   PubMed Web of Science ®Google Scholar
• Chlebowski , RT . 1985 . “Critical Evaluation of the Role of Nutritional Support With Chemotherapy” . Cancer , 55 : 268 – 272 .
   PubMed Web of Science ®Google Scholar
• Clamon , GH , Feld , R , Evans , WK , Weiner , RS Moran , EG . 1985 . “Effect of Adjuvant Central IV Hyper‐alimentation on the Survival and Response to Treatment of Patients With Small Cell Lung Cancer: A Randomized Trial” . Cancer Treat Rep , 69 : 167 – 177 .
   PubMedGoogle Scholar
• Chlebowski , RT . 1985 . “Significance of Altered Nutritional Status in Acquired Immune Deficiency Syndrome (AIDS)” . Nutr Cancer , 7 : 85 – 91 .
   PubMedGoogle Scholar
• Gold , J . 1985 . “Mediating TNF Cachexia” . Med World News , 26 (19) : 169
   Google Scholar